Company:  ARALEZ PHARMACEUTICALS IN ... (ARLZ)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001660719 
Address:  7100 WEST CREDIT AVENUE, SUITE 101 
City, State, Zip:  MISSISSAUGA,  L5N 0E4 
Telephone:  905-876-1118 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.46  
Change: 
-0.02 (-1.35%)  
Trade Time: 
11:32 AM EST  
Market Cap: 
$97.65M
Trade ARLZ now with 

© 2017  
Description of Business
Aralez is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Our parent corporation, Aralez Pharmaceuticals Inc. ("Aralez Parent"), was incorporated under the British Columbia Business Corporations Act ("BCBCA") on December 2, 2015. Our global headquarters is located in Mississauga, Ontario, Canada, our U.S. headquarters is located in Princeton, New Jersey, United States, and our Irish headquarters is located in Dublin, Ireland. Aralez was formed for the purpose of facilitating the business combination of POZEN Inc., a Delaware corporation ("Pozen"), and Tribute Pharmaceuticals Canada Inc., a corporation incorporated under the laws of the Province of Ontario, Canada ("Tribute"), which transaction closed on February 5, 2016.
Register and access this filing in:     
  FORM 8-K
    SECTION 7 REGULATION FD
      Item 7.01. Regulation FD Disclosure.
    SIGNATURE